Introduction {#s1}
============

Carcinoma of the uterine cervix ranks as the second malignant cancer and the third leading cause of cancer deaths in women. Approximately 370,000 new cases are diagnosed annually with a 50% death rate [@pone.0075849-Jemal1], [@pone.0075849-VinhHung1]. Population-based cervical cancer screening and advanced medical treatments have reduced the incidence by 40%--50% and the mortality by 60% in many developed countries. However, the morbidity of cervical cancer in China is still high with almost one-third of the total number worldwide, which remains one of the most important issues in women\'s health care [@pone.0075849-Cao1]. In southwestern China, especially in some rural undeveloped regions, the problem is particularly severe due to the deficiency of regular screening and health care facilities. Previous studies have revealed that ages, FIGO stage, histologic types, depth of stromal invasion (DSI), lymph vascular space invasion (LVSI), and lymph nodes (LN) metastases are aggressive characteristics of cervical cancer, which are regarded as significant factors for treatment, prognosis and recurrence [@pone.0075849-Touboul1]--[@pone.0075849-Delaloye1]. Somehow, these crucial clinic-pathological features have not previously been systematically analyzed and summarized in the last 5 years in southwestern China.

According to some epidemiological reports, the incidence of cervical cancer in young women is rising [@pone.0075849-Parkin1]--[@pone.0075849-Elliott1], while adenocarcinoma is more likely to be found among young patients [@pone.0075849-Bulk1], [@pone.0075849-Grisaru1]. Several authors have reported that carcinoma of cervix had a poorer prognosis and survival rates in young patients than in elder women [@pone.0075849-Clark1], [@pone.0075849-Lau1]--[@pone.0075849-Robertson1], while others found that age has no relevance with the prognosis [@pone.0075849-Junor1]--[@pone.0075849-Carmichael1]. This remained a controversial issue. Additionally, considering the quality of life (QOL), a primary surgery with the radical hysterectomy without bilateral salpingo-oophorectomy is usually performed for young women with cervical cancer [@pone.0075849-Piver1], and patients with postoperative pathological risk factors, such as bulky tumor size, DSI≥1/2, LVSI, LN metastases, parametrial and surgical margin involvement, should often receive adjuvant radiotherapy or concurrent chemotherapy, according to the National Comprehensive Cancer Network (NCCN) clinical practice guidelines of cervical cancer. However, to our best knowledge, there were no systematic studies that compared and analyzed the clinical significance of postoperative pathological risk factors for young women with cervical cancer in southwestern China by assessing the relevance to survivals.

Consequently, the aim of this study was to analyze the clinic-pathological characteristics of women with cervical cancers in southwestern China. The ages, FIGO stages, histology, and the postoperative pathological risk factors were examined. We also discussed the features and prognosis of young patients who were under 35 years old.

Patients and Methods {#s1a}
--------------------

This study was performed at the department of gynecology and obstetrics of West China Second University Hospital, Sichuan, China.

First, a retrospective study was performed. It consisted of 1,543 eligible patients who had been diagnosed with cervical cancer and were undergoing treatment at our hospital between November 2005 and December 2010. Patients were divided into 2 study groups: aged 35 years or younger and over 35 years. Surgical procedures and treatment were selected according to the NCCN clinical practice guidelines of cervical cancer. Clinical and pathological characteristics of the study groups were examined. Correlation analysis and multivariate analysis were employed to further calculate the relevance of FIGO stages to ages and the postoperative pathological risk factors.

Second, in order to discuss the characteristics and prognosis of young patients, 154 young patients with surgical procedures between November 2005 and December 2008 were selected for 5-year follow-up and prognostic analysis. The follow-up included interval history, gynecological examination and cervical smear testing in every 3 months for 1 year, every 6 months for another 2 years, and then annually. Adjuvant radiotherapy or concurrent chemotherapy was performed for patients with postoperative pathological risk factors. Because no invasive examination and sample collection was involved, only verbal consents were required and obtained from young patients or the parents of the patients who were under 18 years old. All verbal consents were documented and listed in a table. The follow-up and consent procedures were approved by Sichuan University Medical Ethical Committee.

Statistical analysis was performed using χ^2^ test, fisher exact test, pearson correlation coefficient and logistic regression analysis. Overall survival was obtained and evaluated by the Kaplan-Meier curve and log-rank test. Prognostic factors were analyzed using Cox proportional hazard models by stepwise selection. *P*\<0.05 was regarded as statistical significance. The SPSS program version 16.0.2 was used for statistical analysis.

Results {#s2}
=======

A total of 312 patients (20.2%) were 35 years or younger between November 2005 and December 2010. [Table 1](#pone-0075849-t001){ref-type="table"} summarized the clinic-pathological characteristics of the study groups. The proportion of being in the advanced FIGO stage (stage IIA-IV) in patients aged over 35 years was higher than the proportion in patients aged 35 years or younger (55.1% vs 38.8%, *P*\<0.001). Patients aged 35 years or younger had a higher rate of bulk tumor size, comparing with patients over 35 years (30.8% vs 23.3%, *P* = 0.008). However, no significant difference of tumor differentiation was found between the two groups.

10.1371/journal.pone.0075849.t001

###### Clinic-pathological characteristics of the study groups.
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                                      N        ≤35 years    \>35 years       P
  ----------------------------- ------------- ------------ ------------- ---------
  Age, year                                                              
  Median                                          33.0         44.0      
  Range                                          17--35       36--75     
  Stage                                                                   \<0.001
  IA1                             133 (8.6)    40 (12.8)     93 (7.6)    
  IA2                             52 (3.4)      17 (5.4)     35 (2.8)    
  IB1                            393 (25.5)    97 (31.1)    296 (24.0)   
  IB2                            165 (10.7)    37 (11.9)    128 (10.4)   
  IIA                            368 (23.8)    53 (17.0)    315 (25.6)   
  IIB                            411 (26.6)    64 (20.5)    347 (28.2)   
  III                             18 (1.2)      4 (1.3)      14 (1.1)    
  IV                               3 (0.2)      0 (0.0)       3 (0.2)    
  Differentiation                                                          1.000
  G1/G2                          185 (12.0)    37 (11.9)    148 (12.0)   
  G3                             1358 (88.0)   275 (88.1)   1083 (88.0)  
  Size                                                                     0.008
  \<4cm                          1160 (75.2)   216 (69.2)   944 (76.7)   
  ≥4cm                           383 (24.8)    96 (30.8)    287 (23.3)   
  Histological type                                                        0.574
  Squamous                       1325 (85.9)   265 (84.9)   1060 (86.1)  
  Non-squamous                   187 (12.1)    41 (13.1)    146 (11.9)   
  Adenocarcinoma                  78 (5.1)      18 (5.8)     60 (4.9)    
   Adenosquamous cell             95 (6.2)      20 (6.4)     75 (6.1)    
   MMMT                            2 (0.1)      1 (0.3)       1 (0.1)    
   Small cell                     16 (1.0)      5 (1.6)      11 (0.9)    
   Clear cell                      6 (0.4)      0 (0.0)       6 (0.5)    
   Leiomyosarcoma                  2 (0.1)      1 (0.3)       1 (0.1)    
   Adenosarcoma                    2 (0.1)      0 (0.0)       2 (0.2)    
   Others                         17 (1.1)      2 (0.6)       15(1.2)    
  DSI                                                                      0.014
  \<1/2                          622 (40.3)    145 (46.5)   477 (38.7)   
  ≥1/2                           921 (59.7)    167 (53.5)   754 (61.3)   
  LVSI                                                                     0.397
  Negative                       951 (61.6)    199 (63.8)   752 (61.1)   
  Positive                       592 (38.4)    113 (36.2)   479 (38.9)   
  LN metastases                                                            0.299
  Negative                       1243 (80.6)   258 (82.7)   985 (80.0)   
  Positive                       300 (19.4)    54 (17.3)    246 (20.0)   
  Parametrial involvement                                                  0.367
  Negative                       1443 (93.5)   288 (92.3)   1155 (93.8)  
  Positive                        100 (6.5)     24 (7.7)     76 (6.2)    
  Surgical margin involvement                                              1.000
  Negative                       1496 (97.0)   303 (97.1)   1193 (96.9)  
  Positive                        47 (3.0)      9 (2.9)      38 (3.1)    

As shown in [Table 1](#pone-0075849-t001){ref-type="table"}, non-squamous histological type included adenocarcinoma, adenosquamous cell carcinoma, malignant mixed mullerian tumor (MMMT), small cell carcinoma, clear cell carcinoma, leiomyosarcoma, adenosarcoma and other classified carcinoma. Squamous cell carcinoma was the main histological type. However, there was no significant difference of the histological type between the two groups. For the postoperative pathological risk factors, a lower rate of DSI≥1/2 was found in patients aged 35 years or younger, comparing with the rate in patients aged over 35 years (53.5% vs 61.3%, *P* = 0.014). In addition, the differences in LVSI, LN metastases, parametrial and surgical margin involvement between the two groups were insignificant.

A positive correlation was found between FIGO stages and the postoperative pathological risk factors (*P*\<0.05) ([Table 2](#pone-0075849-t002){ref-type="table"}). Furthermore, multivariate analysis revealed that ages, DSI, LN metastases and parametrial involvement were significantly related to FIGO stages (*P*\<0.05) ([Table 3](#pone-0075849-t003){ref-type="table"}).

10.1371/journal.pone.0075849.t002

###### The correlation between FIGO stage and postoperative pathological risk factors.
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                                 Early stage   Advanced stage     r       P
  ----------------------------- ------------- ---------------- ------- -------
  DSI                                                           0.280   0.000
  \<1/2                          543 (48.9)      79 (18.3)             
  ≥1/2                           568 (51.1)      353 (81.7)            
  LVSI                                                          0.143   0.000
  Negative                       733 (66.0)      218 (50.5)            
  Positive                       378 (34.0)      214 (49.5)            
  LN metastases                                                 0.201   0.000
  Negative                       950 (85.5)      293 (67.8)            
  Positive                       161 (14.5)      139 (32.2)            
  Parametrial involvement                                       0.164   0.000
  Negative                       1067 (96.0)     376 (87.0)            
  Positive                        44 (4.0)       56 (13.0)             
  Surgical margin involvement                                   0.066   0.010
  Negative                       1085 (97.7)     411 (95.1)            
  Positive                        26 (2.3)        21 (4.9)             

10.1371/journal.pone.0075849.t003

###### The relevance of FIGO stage to age and postoperative pathological risk factors.
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                                  OR        95%CI        P
  ----------------------------- ------- ------------- -------
  Age                            1.428   1.045∼1.950   0.025
  DSI                            3.502   2.647∼4.634   0.000
  LVSI                           1.193   0.931∼1.527   0.163
  LN metastases                  1.792   1.345∼2.387   0.000
  Parametrial involvement        1.881   1.209∼2.924   0.000
  Surgical margin involvement    1.162   0.614∼2.199   0.644

Between November 2005 and December 2008, 154 young patients were treated at our department. The clinic-pathological features were summarized in [Table 4](#pone-0075849-t004){ref-type="table"}. Adenocarcinoma of cervix remained high in young patients (13.6%). A total of 136 patients (88.3%) were diagnosed with poor differentiation. Young patients with adenocarcinoma had a higher rate of well differentiation than those with squamous cell carcinoma (28.6% vs 9.0%, *P* = 0.010). There was no difference between patients with squamous cell carcinoma and patients with adenocarcinoma regarding their FIGO stages, treatment (treated with surgery or neoadjuvant chemotherapy), DSI, LVSI, parametrial and surgical margin involvement. However, young women with cervical adenocarcinoma had a higher rate of LN metastases than those with squamous cell carcinoma (42.9% vs 15.8%, *P* = 0.004).

10.1371/journal.pone.0075849.t004

###### Clinic-pathological features of 154 patients aged 35 years or younger.
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                                                     N       Squamous    Adenocarcinoma     P
  --------------------------------------------- ----------- ----------- ---------------- -------
  Stage                                                                                   0.782
  Early                                          106(68.8)   91(68.4)       15(71.4)     
  Advanced                                       48(31.2)    15(31.6)       6(28.6)      
  Differentiation                                                                         0.010
  G1/G2                                          18(11.7)     12(9.0)       6(28.6)      
  G3                                             136(88.3)   121(91.0)      15(71.4)     
  Treatment                                                                               0.251
  Surgery                                        123(79.9)   104(78.2)      19(90.5)     
  Neoadjuvant chemotherapy                       31(20.1)    29(21.8)        2(9.5)      
  DSI                                                                                     0.076
  \<1/2                                          64(41.6)    59(44.4)       5(23.8)      
  ≥1/2                                           90(58.4)    74(55.6)       16(76.2)     
  LVSI                                                                                    0.197
  Negative                                       86(55.8)    77(57.9)       9(42.9)      
  Positive                                       68(44.2)    56(42.1)       12(57.1)     
  LN metastases                                                                           0.004
  Negative                                       124(80.5)   112(84.2)      12(57.1)     
  Positive                                       30(19.5)    21(15.8)       9(42.9)      
  Parametrial and Surgical margin involvement                                             0.647
  Negative                                       143(92.9)   124(93.2)      19(90.5)     
  Positive                                        11(7.1)     9(6.8)         2(9.5)      

Young patients in early FIGO stage who had adenocarcinoma had significantly shorter progression-free survival comparing with those who had squamous cell carcinoma (*P* = 0.024) ([Fig. 1](#pone-0075849-g001){ref-type="fig"}-A). However, no matter what the histological type is, young patients in advanced FIGO stage all had short progression-free survival ([Fig. 1](#pone-0075849-g001){ref-type="fig"}-B).

![Kaplan-Meier analysis of progression-free survival.\
(A) PFS of young patients with early FIGO stage stratified by histological type (log-rank test *P* = 0.024). (B) PFS of young patients with advanced FIGO stage stratified by histological type (log-rank test *P* = 0.584).](pone.0075849.g001){#pone-0075849-g001}

Patients aged 35 years or younger with positive postoperative pathological risk factors (DSI≥1/2, LN metastases, LVSI, parametrial and surgical margin involvement) had significantly shorter progression-free survival than those with negative factors (*P*\<0.01) ([Fig. 2](#pone-0075849-g002){ref-type="fig"})

![Progression-free survival of young patients with different pathological risk factors.\
(A) PFS of young patients stratified by DSI (log-rank test *P* = 0.005). (B) PFS of young patients stratified by LN metastases (log-rank test *P* = 0.000). (C) PFS of young patients stratified by LVSI (log-rank test *P* = 0.000). (D) PFS of young patients stratified by parametrial and surgical margin involvement (log-rank test *P* = 0.006).](pone.0075849.g002){#pone-0075849-g002}

Prognostic analysis with the Cox proportional hazard model demonstrated that the prognostic factors of histological types and LN metastases were statistically significant among young patients in southwestern China ([Table 5](#pone-0075849-t005){ref-type="table"}).

10.1371/journal.pone.0075849.t005

###### Prognostic factors analyzed by Cox proportional hazard models for young patients.
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  Prognostic factors                             Hazard ratio       95%CI          P
  --------------------------------------------- -------------- ---------------- -------
  Stage                                             0.435        0.117∼1.622     0.215
  Histological type                                 0.187        0.035∼0.988     0.048
  Differentiation                                   0.644        0.131∼3.173     0.589
  Treatment                                         0.727        0.220∼2.407     0.602
  DSI                                               2.537        0.486∼13.253    0.270
  LN metastases                                     48.533      11.238∼209.603   0.000
  LVSI                                              2.113        0.689∼6.483     0.191
  Parametrial and Surgical margin involvement       2.560        0.607∼10.801    0.201

Discussion {#s3}
==========

In recent years, the cervical cancer rate is decreasing in some developed countries, although incidence remains high among Asian women [@pone.0075849-BarnholtzSloan1]--[@pone.0075849-Sherman1]. The global annual incidence of cervical cancer was 493,200 in 2002, and the yearly death rate was 273,500, which is the third most common cancer in women worldwide [@pone.0075849-Parkin1]. According to epidemiological reports, 78% of cases occurred in developing countries, where cervical cancer was the second most frequent cause of cancer death in women [@pone.0075849-Kamangar1]. In China, the morbidity of cervical cancer is still high with almost one-third of the total number worldwide, which remains a major health problem for women in China [@pone.0075849-Cao1]. The problem is particularly severe in southwestern China due to the less-than--ideal medical condition.

The clinical stage of cervical cancer is definitely important for primary treatment and prognosis. Our results showed that the staging distribution was significantly different between the two study groups. Patients aged over 35 years had a higher proportion of being in the advanced FIGO stage, comparing with patients aged 35 years or younger. Furthermore, the preoperatively-diagnosed advanced FIGO stage might predict a higher potential of having postoperative pathological risk factors. In southwestern China, especially some rural regions, middle-aged and elderly women have little awareness of cervical cancer or the knowledge of its detection method. Besides, it is reported that pap smear screening is of great importance for detecting cervical cancer in the absence of symptoms [@pone.0075849-McMullin1], [@pone.0075849-Hoque1]. Consequently, this is why most patients over 35 years were preliminarily diagnosed as being in the advanced FIGO stage with poor prognosis. As a result, we re-emphasize the importance of health education and regular smear screening for middle-aged and elderly women in southwestern China.

Currently, the staging of cervical cancer remains largely a clinical evaluation, although surgical staging is more accurate, but it cannot be easily implemented in low resource regions [@pone.0075849-FUTURE1]--[@pone.0075849-Pecorelli1]. The FIGO system limits the imaging examination to chest radiography, intravenous pyelography (IVP) and barium enema. It cannot comprehensively and systematically evaluate the involvement of pelvic tissues and organs. Our result demonstrated that patients in the advanced FIGO stage were more likely to have deep stromal invasion, LVSI, LN metastases, and parametrial and surgical margin involvement. Furthermore, multivariate analysis revealed that ages, DSI, LN metastases and parametrial involvement had statistically strong correlation to FIGO stages. Therefore, radiographic methods such as CT, MRI and PET-CT should be applied in order to thoroughly evaluate the DSI, LN metastases and parametrial involvement for patients in the advanced FIGO stage. In addition, the medical costs of physical examination should be reconsidered and reduced by health organizations.

Some reports have shown that the incidence of cervical cancer in young women is rising [@pone.0075849-Parkin1]--[@pone.0075849-Elliott1]. In our study, 312 patients (20.2%) were 35 years or younger in the last 5 years. This proportion is still higher than epidemiological data from other regions or countries [@pone.0075849-Lau1], [@pone.0075849-Liu1]. Persistent human papillomavirus (HPV) infection and early age of onset coitus, which causes atypical hyperplasia in young women, are regarded as the most crucial factors contributing to the development of cervical cancer [@pone.0075849-Moscicki1]--[@pone.0075849-Frega1]. The primary HPV infection site is squamous-columnar (S-C) junction of the cervical epithelium, where cells have active proliferation. For young women, the S-C junction is exposed at the exocervix, where cells are more vulnerable to HPV infection if she has an early age of onset coitus. In addition, estrogen-excessive pregnant status leads to cervical ectropion and vulnerability. As a result, immunization against HPV, especially for young women, is expected to prevent specific HPV related cervical cancer [@pone.0075849-Gold1], [@pone.0075849-Moore1].

It is reported that adenocarcinoma of the cervix has increased over the last 3 decades accounting for about 20% of all cervical cancers and the survival of patients with adenocarcinoma has not changed significantly. Meanwhile adenocarcinoma has been more likely to be found among young women [@pone.0075849-Bulk1], [@pone.0075849-Grisaru1]. Our results showed that adenocarcinoma of cervix remained at a high level in young patients. This is probably caused by defection of cervical cytologic screening methods for adenocarcinoma [@pone.0075849-Sherman1], [@pone.0075849-Sasieni1], and that young patients with cervical adenocarcinoma had a higher risk of LN metastases. Therefore, a shorter progression-free survival was found in young patients with adenocarcinoma, especially those in the early FIGO stage. In addition, we also demonstrated that positive postoperative pathological factors, such as deep stromal invasion, LVSI, LN metastases, and parametrial and surgical margin involvement, could apparently worsen the prognosis of young patients with cervical cancer. Previous study showed that FIGO stages, histological and postoperative pathological factors were found to be prognostic factors of cervical cancer [@pone.0075849-VinhHung1], [@pone.0075849-Touboul1]--[@pone.0075849-Delaloye1]. In this study, with the help of statistical analysis, histological type and LN metastases were found to be the most significant independent prognostic factors for young patients in southwestern China. Consequently, we should pay more attention to young patients with adenocarcinoma or LN metastases and reconsider the use of adjuvant radiotherapy or concurrent chemotherapy to improve their prognosis, although this method is hard to be accepted by some young women considering side effects, menopausal syndrome, economical affordability and quality of life (QOL).

In conclusion, we found that patients over 35 years who were preliminarily diagnosed as being in the advanced FIGO stage were more likely to have deep stromal invasion, LVSI, LN metastases, parametrial and surgical margin involvement. Regarding young patients, adenocarcinoma of cervix remained high and increased the risk of LN metastases, and positive postoperative pathological factors could apparently worsen the prognosis. Furthermore, histological types and LN metastases were the most significant independent prognostic factors for young patients in southwestern China. We therefore re-emphasize the importance of health education and regular smear screening for middle-aged and elderly women. In addition, we should pay more attention to young patients with adenocarcinoma or LN metastases and reconsider the use of adjuvant radiotherapy or concurrent chemotherapy to improve their prognosis, although this may be hard to be accepted.
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